Printer Friendly

Acne gel approved.

The Food and Drug Administration has approved Veltin, gel containing clindamycin phosphate and tretinoin, for the topical treatment of acne vulgaris in patients aged 12 years and older.

The treatment brings together a topical retinoid and an antibiotic--which are often recommended for the treatment of acne vulgaris--in a water-based gel.

Veltin (1.2% clindamycin phosphate and 0.025% tretinoin) should not be used by patients who have Crohn's disease or ulcerative colitis or have developed colitis with past antibiotic use. Patients using the treatment should avoid exposure to sunlight and sun lamps and should wear sunscreen daily.

Stiefel Laboratories Inc., a GlaxoSmithKline company, expects the gel to be available by prescription later this year.
COPYRIGHT 2010 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:NEWS FROM THE FDA
Publication:Internal Medicine News
Date:Sep 1, 2010
Words:114
Previous Article:Risk of suicide spurs rimonabant trial to end.
Next Article:Warning on Vision Centers.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters